Sanofi has acquired Zentiva Slovakia
The public shareholders of Zentiva Slovakia have sold approximately a 3% stake in the company to Sanofi, in a share buyback transaction. Financial details have not been disclosed.
Sanofi is a global and diversified healthcare leader which researches, develops and distributes therapeutic solutions focused on patients’ needs. The company has core strengths in healthcare, with six growth platforms: emerging markets, vaccines, consumer healthcare, diabetes treatments, innovative products and animal health.
Zentiva Slovakia is a producer of pharmaceutical products. Its product range consists of approximately 270 references in 500 pharmaceutical presentations, of which 180 are bound by prescription and 100 are OTC preparations or food supplements. The company focuses on the treatment of cardiovascular disorders, inflammatory conditions, pain, infections and diseases of the central nervous system and the gastrointestinal and urinary tracts. It also offers over-the-counter medicines and dietary supplements. It offers a range of therapeutic areas. In addition to generic drugs, Zentiva Slovakia also produces cosmetics and pharmaceutical substances.
Oaklins' team in Slovakia acted as financial advisor to the buyer in this transaction.
Talk to the deal team
Managing DirectorPrague, Czech Republic
Oaklins WOOD & Co.
BlijWerkt has been acquired by Mentha Capital
Gilde Healthcare Partners has sold BlijWerkt Groep B.V. to Mentha Capital.Learn more
Medical Mutual of Ohio has acquired Bravo Wellness, LLC
Medical Mutual of Ohio on the acquisition of Bravo Wellness, LLC.Learn more
Lead Healthcare has successfully raised financing provided by Rabobank
Lead Healthcare has successfully raised financing provided by Rabobank.Learn more